ADAM VOGEL to Double-Blind Method
This is a "connection" page, showing publications ADAM VOGEL has written about Double-Blind Method.
Connection Strength
0.100
-
Rationale and study design for the first precision medicine randomized placebo-controlled trial in the 16p11.2 deletion syndrome. Expert Rev Neurother. 2026 Jun; 26(6):597-607.
Score: 0.046
-
Double blind trial of a deuterated form of linoleic acid (RT001) in Friedreich ataxia. J Neurol. 2023 Mar; 270(3):1615-1623.
Score: 0.036
-
Vocal acoustic biomarkers of depression severity and treatment response. Biol Psychiatry. 2012 Oct 01; 72(7):580-7.
Score: 0.017